Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADMA | AMGN | BMY | GILD | ILMN |
| Company | Adma Biologics | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 19.87 | 335.15 | 49.29 | 83.26 | 133.64 |
| High | 20.16 | 338.97 | 49.53 | 83.99 | 133.64 |
| Low | 19.43 | 334.27 | 49.00 | 82.75 | 130.36 |
| Last | 19.98 | 337.38 | 49.41 | 83.94 | 131.20 |
| Change | +0.24 | +1.43 | +0.39 | +0.04 | -3.19 |
| % Change | +1.22% | +0.43% | +0.80% | +0.05% | -2.37% |
| Volume | 45,181,902 | 4,068,200 | 27,106,500 | 24,925,900 | 2,659,500 |
| 20-Day Average Volume | 6,590,825 | 1,855,500 | 9,468,165 | 7,644,690 | 1,435,735 |
| Previous Close | 19.74 | 335.95 | 49.02 | 83.90 | 134.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 17.78 | 330.23 | 49.18 | 80.47 | 129.29 |
| 20-Day Raw Stochastic | 95.61% | 91.90% | 60.24% | 89.42% | 68.17% |
| 20-Day Relative Strength | 68.41% | 58.76% | 55.67% | 71.95% | 55.98% |
| Weighted Alpha | +403.67 | +27.84 | -10.22 | +18.32 | +4.95 |
| Today's Opinion | 100% Buy | 100% Buy | 72% Buy | 88% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 96% Buy | 56% Buy | 88% Buy | 72% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 40% Buy | 56% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.45% since 09/13/24 | +1.48% since 09/13/24 | +0.57% since 09/13/24 | +1.36% since 09/13/24 | +1.56% since 09/13/24 |
| Low | 17.70 on 09/16/24 | 331.00 on 09/18/24 | 48.78 on 09/18/24 | 82.38 on 09/17/24 | 127.50 on 09/16/24 |
| High | 20.16 on 09/20/24 | 339.00 on 09/18/24 | 50.41 on 09/17/24 | 84.65 on 09/19/24 | 136.19 on 09/19/24 |
| 1-Month | |||||
| %Chg | +11.43% since 08/20/24 | +2.69% since 08/20/24 | +0.88% since 08/20/24 | +12.29% since 08/20/24 | -0.99% since 08/20/24 |
| Low | 16.06 on 09/04/24 | 319.00 on 09/06/24 | 46.88 on 08/22/24 | 74.80 on 08/21/24 | 120.51 on 09/12/24 |
| High | 20.16 on 09/20/24 | 339.00 on 09/18/24 | 50.75 on 09/04/24 | 84.89 on 09/12/24 | 136.19 on 09/19/24 |
| 3-Month | |||||
| %Chg | +86.55% since 06/20/24 | +8.87% since 06/20/24 | +20.39% since 06/20/24 | +22.56% since 06/20/24 | +21.20% since 06/20/24 |
| Low | 10.21 on 08/05/24 | 306.11 on 07/03/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 103.52 on 06/28/24 |
| High | 20.16 on 09/20/24 | 346.85 on 07/25/24 | 51.19 on 07/29/24 | 84.89 on 09/12/24 | 137.18 on 08/20/24 |
| 6-Month | |||||
| %Chg | +216.14% since 03/20/24 | +23.56% since 03/20/24 | -4.76% since 03/20/24 | +13.46% since 03/20/24 | -1.49% since 03/20/24 |
| Low | 5.89 on 04/10/24 | 260.68 on 04/19/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 | 100.08 on 05/30/24 |
| High | 20.16 on 09/20/24 | 346.85 on 07/25/24 | 54.47 on 03/28/24 | 84.89 on 09/12/24 | 144.19 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,631,544 | 180,982,432 | 100,159,008 | 104,576,912 | 20,900,160 |
| Shares Outstanding, K | 231,809 | 536,435 | 2,027,100 | 1,245,853 | 159,300 |
| Annual Sales | 258,220,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -28,240,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 107,190,000 | 8,388,000,000 | 12,201,000,000 | 6,954,000,000 | 1,112,000,000 |
| Last Quarter Net Income | 32,060,000 | 746,000,000 | 1,680,000,000 | 1,614,000,000 | -1,988,000,000 |
| 60-Month Beta | 0.61 | 0.61 | 0.46 | 0.18 | 1.15 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 08/08/24 | 4.97 on 08/06/24 | 2.07 on 07/26/24 | 2.01 on 08/08/24 | 0.36 on 08/06/24 |
| Latest Earnings Date | 11/13/24 | 10/29/24 | 10/31/24 | 11/05/24 | 11/14/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.600 on 07/05/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 10/04/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 75.92 | 18.06 | 35.78 | 17.85 | 146.08 |